Literature DB >> 34169340

Two-Pore Domain Potassium Channel in Neurological Disorders.

Punita Aggarwal1, Sanjiv Singh2, V Ravichandiran1.   

Abstract

K2P channel is the leaky potassium channel that is critical to keep up the negative resting membrane potential for legitimate electrical conductivity of the excitable tissues. Recently, many substances and medication elements are discovered that could either straightforwardly or in a roundabout way influence the 15 distinctive K+ ion channels including TWIK, TREK, TASK, TALK, THIK, and TRESK. Opening and shutting of these channels or any adjustment in their conduct is thought to alter the pathophysiological condition of CNS. There is no document available till now to explain in detail about the molecular mechanism of agents acting on K2P channel. Accordingly, in this review we cover the current research and mechanism of action of these channels, we have also tried to mention the detailed effect of drugs and how the channel behavior changes by focusing on recent advances regarding activation and modulation of ion channels.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  K2P channels; TALK; TASK; THIK; TREK; TWIK

Mesh:

Substances:

Year:  2021        PMID: 34169340     DOI: 10.1007/s00232-021-00189-8

Source DB:  PubMed          Journal:  J Membr Biol        ISSN: 0022-2631            Impact factor:   1.843


  91 in total

1.  TREK2 expressed selectively in IB4-binding C-fiber nociceptors hyperpolarizes their membrane potentials and limits spontaneous pain.

Authors:  Cristian Acosta; Laiche Djouhri; Roger Watkins; Carol Berry; Kirsty Bromage; Sally N Lawson
Journal:  J Neurosci       Date:  2014-01-22       Impact factor: 6.167

Review 2.  Targeting two-pore domain K(+) channels TREK-1 and TASK-3 for the treatment of depression: a new therapeutic concept.

Authors:  M Borsotto; J Veyssiere; H Moha Ou Maati; C Devader; J Mazella; C Heurteaux
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

3.  TASK Channels Pharmacology: New Challenges in Drug Design.

Authors:  Mauricio Bedoya; Susanne Rinné; Aytug K Kiper; Niels Decher; Wendy González; David Ramírez
Journal:  J Med Chem       Date:  2019-07-15       Impact factor: 7.446

4.  Diazoxide in the treatment of schizophrenia: novel application of potassium channel openers in the treatment of schizophrenia.

Authors:  S Akhondzadeh; V Mojtahedzadeh; G-R Mirsepassi; M Moin; H Amini-Nooshabadi; A Kamalipour
Journal:  J Clin Pharm Ther       Date:  2002-12       Impact factor: 2.512

5.  Tandem pore domain halothane-inhibited K+ channel subunits THIK1 and THIK2 assemble and form active channels.

Authors:  Sandy Blin; Franck C Chatelain; Sylvain Feliciangeli; Dawon Kang; Florian Lesage; Delphine Bichet
Journal:  J Biol Chem       Date:  2014-08-22       Impact factor: 5.157

6.  Ion channels and schizophrenia: a gene set-based analytic approach to GWAS data for biological hypothesis testing.

Authors:  Kathleen Askland; Cynthia Read; Chloe O'Connell; Jason H Moore
Journal:  Hum Genet       Date:  2011-08-25       Impact factor: 4.132

7.  The two-pore domain potassium channel TREK-1 mediates cardiac fibrosis and diastolic dysfunction.

Authors:  Dennis M Abraham; Teresa E Lee; Lewis J Watson; Lan Mao; Gurangad Chandok; Hong-Gang Wang; Stephan Frangakis; Geoffrey S Pitt; Svati H Shah; Matthew J Wolf; Howard A Rockman
Journal:  J Clin Invest       Date:  2018-10-02       Impact factor: 14.808

8.  TREK-1, a K+ channel involved in polymodal pain perception.

Authors:  Abdelkrim Alloui; Katharina Zimmermann; Julien Mamet; Fabrice Duprat; Jacques Noël; Jean Chemin; Nicolas Guy; Nicolas Blondeau; Nicolas Voilley; Catherine Rubat-Coudert; Marc Borsotto; Georges Romey; Catherine Heurteaux; Peter Reeh; Alain Eschalier; Michel Lazdunski
Journal:  EMBO J       Date:  2006-05-04       Impact factor: 11.598

9.  Motoneurons express heteromeric TWIK-related acid-sensitive K+ (TASK) channels containing TASK-1 (KCNK3) and TASK-3 (KCNK9) subunits.

Authors:  Allison P Berg; Edmund M Talley; Jules P Manger; Douglas A Bayliss
Journal:  J Neurosci       Date:  2004-07-28       Impact factor: 6.167

10.  Changes in expression of some two-pore domain potassium channel genes (KCNK) in selected brain regions of developing mice.

Authors:  M I Aller; W Wisden
Journal:  Neuroscience       Date:  2007-12-23       Impact factor: 3.590

View more
  3 in total

1.  Receptor and Ionic Mechanism of Histamine on Mouse Dorsolateral Striatal Neurons.

Authors:  Jian-Ya Peng; Kang-Li Shen; Xiu-Juan Fan; Zeng-Xin Qi; Hui-Wei Huang; Jian-Lan Jiang; Jian-Hua Lu; Xiao-Qin Wang; Xiao-Xia Fang; Wang-Rui Yuan; Qiao-Xuan Deng; Shu Chen; Liang Chen; Qian-Xing Zhuang
Journal:  Mol Neurobiol       Date:  2022-10-17       Impact factor: 5.682

Review 2.  Peripheral Voltage-Gated Cation Channels in Neuropathic Pain and Their Potential as Therapeutic Targets.

Authors:  Sascha R A Alles; Peter A Smith
Journal:  Front Pain Res (Lausanne)       Date:  2021-12-13

Review 3.  Interaction of Medicinal Plants and Their Active Constituents With Potassium Ion Channels: A Systematic Review.

Authors:  Arezoo Rajabian; Fatemeh Rajabian; Fatemeh Babaei; Mohammadreza Mirzababaei; Marjan Nassiri-Asl; Hossein Hosseinzadeh
Journal:  Front Pharmacol       Date:  2022-02-22       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.